Cardiopulmonary Exercise Testing in the Age of New Heart Failure Therapies: Still a Powerful Tool?

Cardiopulmonary Exercise Testing in the Age of New Heart Failure Therapies: Still a Powerful Tool?

Background: New therapies with prognostic benefits have been recently introduced in heart failure with reduced ejection fraction (HFrEF) management. The aim of this study was to evaluate the prognostic power of current listing criteria for heart transplantation (HT) in an HFrEF cohort submitted to c...

Full description

Bibliographic Details
Main Authors: Pedro Garcia Brás, António Valentim Gonçalves, João Ferreira Reis, Rita Ilhão Moreira, Tiago Pereira-da-Silva, Pedro Rio, Ana Teresa Timóteo, Sofia Silva, Rui M. Soares, Rui Cruz Ferreira
Format: Article
Language:English
Published: MDPI AG 2023-08-01
Series:Biomedicines
Subjects:
heart failure with reduced ejection fraction
cardiorespiratory exercise testing
heart failure therapies
heart transplantation
peak oxygen consumption
VE/VCO<sub>2</sub> slope
Online Access:https://www.mdpi.com/2227-9059/11/8/2208

Internet

https://www.mdpi.com/2227-9059/11/8/2208

Similar Items